Skip to main content
. 2024 Dec 27;17:200. doi: 10.1186/s12245-024-00801-3

Table 1.

Disease changes and treatment procedures

Time node Clinical manifestation Examination and treatment
Feb. 12th 2023 Upper abdominal pain for 17 days Hb 71 → 45g/L, CT showed retroperitoneal hematoma with no contrast medium leakage
Feb. 13th 2023 Fever and jaundice Blood transfusion, anti-infection
Feb. 18th 2023 None CT roughly the same as before
Feb. 25th 2023 Infection state almost controlled Deventilation and extubation
Feb. 27th 2023 Gastric tube drainage with a intermittent bright red - reddish-brown fluid Fasting for solids and liquids
Feb. 28th 2023 Same as above Arrived at the emergency department of PUMCH
Mar. 1st 2023 Low fever, abdominal pain Admitted to the emergency generalized ward, plasma infusion, anti-infection, cooling, pain relief, rehydration,
Mar. 2nd 2023 Reddish brown of gastric tube drainage Transferred to EICU and red blood cells, plasma, human fibrinogen, PCCs, vitamin K1 were infused
Mar. 4th 2023 Symptoms were improved Back to the general ward
Mar. 8th to 24th 2023 Transit to liquid diet without discomfort gradually

Myocardium and abdominal wall biopsy pathology λ + , congo red + , consistent with

amyloidosis (AL-λ type)

Mar. 24th 2023 Same as above Transferred to the hematology department, developed fever again
Mar. 28th 2023 Same as above Comprehensive discussion by the professional team
Mar. 29th 2023 Same as above Daretumab + bortezomib + dexamethasone